Evidence map›Paper›PMID 17329276›Full record

Trial reportArchives of disease in childhood. Fetal and neonatal edition2007

Dopamine versus dobutamine in very low birthweight infants: endocrine effects.

Luca Filippi, Marco Pezzati, Chiara Poggi, Sauro Rossi, Alessandra Cecchi, Cristina Santoro

Open access · greenAbstract readComparative StudyRandomized Controlled Trial
In one paragraph

Trial report in Archives of disease in childhood. Fetal and neonatal edition, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 3 pooled it
0.7field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 3 syntheses or guidelines pooled it, 68 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. A meta-analysis of dopamine use in hypotensive preterm infants: blood pressure and cerebral hemodynamics.Journal of perinatology : official journal of the California Perinatal Association · 2011
    Pooled it
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Review
  9. Observational
  10. Article
  11. Article
  12. Congenital hypothyroidism with delayed thyroid-stimulating hormone elevation in premature infants born at less than 30 weeks gestation.Journal of perinatology : official journal of the California Perinatal Association · 2017
    Article
  13. Article
  14. Response to dopamine in prematurity: a biomarker for brain injury?Journal of perinatology : official journal of the California Perinatal Association · 2016
    Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Luca FilippiNeonatal Intensive Care Unit, Department of Critical Care Medicine, Meyer University Hospital, via L. Giordano, 13 I-50132 Florence, Italy. filippi.luca@virgilio.it
Marco Pezzati
Chiara Poggi
Sauro Rossi
Alessandra Cecchi
Cristina Santoro
Meyer Children's Hospital · ITAzienda Ospedaliero-Universitaria Careggi · ITNuovo Ospedale San Giovanni di Dio · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo compare the endocrine effects of dopamine and dobutamine in hypotensive very low birthweight (VLBW) infants.

designNon-blinded randomised prospective trial.

settingLevel III neonatal intensive care unit. PATIENTS: 35 hypotensive VLBW infants who did not respond to volume loading, assigned to receive dopamine or dobutamine. MEASUREMENTS: Haemodynamic variables and serum levels of thyroid stimulating hormone (TSH), total thyroxine (T(4)), prolactin (PRL) and growth hormone were assessed during the first 72 h of treatment and the first 72 h after stopping treatment.

resultsDemographic and clinical data did not significantly differ between the two groups. Necessary cumulative and mean drug doses and maximum infusion required to normalise blood pressure were significantly higher in the dobutamine than in the dopamine group (p<0.01). Suppression of TSH, T(4) and PRL was observed in dopamine-treated newborns from 12 h of treatment onwards, whereas levels of growth hormone reduced significantly only at 12 h and 36 h of treatment (p<0.01). TSH, T(4) and PRL rebound was observed from the first day onwards after stopping dopamine. Dobutamine administration did not alter the profile of any of the hormones and no rebound was observed after stopping treatment.

conclusionDopamine and dobutamine both increase the systemic blood pressure, though dopamine is more effective. Dopamine reduces serum levels of TSH, T(4) and PRL in VLBW infants but such suppression is quickly reversed after treatment is stopped. Further research is required to assess if short-term iatrogenic pituitary suppression has longer-term consequences.

Indexed as

Infant, Very Low Birth WeightBlood PressureCardiotonic AgentsDobutamineDopamineFemaleHeart RateHuman Growth HormoneHumansHypotensionInfant, NewbornIntensive Care, NeonatalMaleProlactinProspective StudiesThyrotropinCardiotonic AgentsDobutamineDopamineHuman Growth HormoneProlactinThyrotropinThyroxine

Identifiers

PMID17329276
PMCPMC2675359
OpenAlexW2171486675

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.